Skip to main content

Research Repository

Advanced Search

TAAR1 Modulates Cortical Glutamate NMDA Receptor Function

Benfenati, Fabio; Espinoza, Stefano; Lignani, Gabriele; Caffino, Lucia; Maggi, Silvia; Sukhanov, Ilya; Leo, Damiana; Mus, Liudmila; Emanuele, Marco; Ronzitti, Giuseppe; Harmeier, Anja; Medrihan, Lucian; Sotnikova, Tatyana D; Chieregatti, Evelina; Hoener, Marius C; Tucci, Valter; Fumagalli, Fabio; Gainetdinov, Raul R

Authors

Fabio Benfenati

Stefano Espinoza

Gabriele Lignani

Lucia Caffino

Ilya Sukhanov

Damiana Leo

Liudmila Mus

Marco Emanuele

Giuseppe Ronzitti

Anja Harmeier

Lucian Medrihan

Tatyana D Sotnikova

Evelina Chieregatti

Marius C Hoener

Valter Tucci

Fabio Fumagalli

Raul R Gainetdinov



Abstract

Trace Amine-Associated Receptor 1 (TAAR1) is a G protein-coupled receptor expressed in the mammalian brain and known to influence subcortical monoaminergic transmission. Monoamines, such as dopamine, also play an important role within the prefrontal cortex (PFC) circuitry, which is critically involved in high-o5rder cognitive processes. TAAR1-selective ligands have shown potential antipsychotic, antidepressant, and pro-cognitive effects in experimental animal models; however, it remains unclear whether TAAR1 can affect PFC-related processes and functions. In this study, we document a distinct pattern of expression of TAAR1 in the PFC, as well as altered subunit composition and deficient functionality of the glutamate N-methyl-D-aspartate (NMDA) receptors in the pyramidal neurons of layer V of PFC in mice lacking TAAR1. The dysregulated cortical glutamate transmission in TAAR1-KO mice was associated with aberrant behaviors in several tests, indicating a perseverative and impulsive phenotype of mutants. Conversely, pharmacological activation of TAAR1 with selective agonists reduced premature impulsive responses observed in the fixed-interval conditioning schedule in normal mice. Our study indicates that TAAR1 plays an important role in the modulation of NMDA receptor-mediated glutamate transmission in the PFC and related functions. Furthermore, these data suggest that the development of TAAR1-based drugs could provide a novel therapeutic approach for the treatment of disorders related to aberrant cortical functions.

Citation

Benfenati, F., Espinoza, S., Lignani, G., Caffino, L., Maggi, S., Sukhanov, I., …Gainetdinov, R. R. (2015). TAAR1 Modulates Cortical Glutamate NMDA Receptor Function. Neuropsychopharmacology, 40(9), 2217-2227. https://doi.org/10.1038/npp.2015.65

Journal Article Type Article
Acceptance Date Feb 25, 2015
Online Publication Date Mar 9, 2015
Publication Date 2015-08
Deposit Date Nov 4, 2019
Publicly Available Date Nov 4, 2019
Journal Neuropsychopharmacology
Print ISSN 0893-133X
Electronic ISSN 1740-634X
Publisher Nature Publishing Group
Peer Reviewed Peer Reviewed
Volume 40
Issue 9
Pages 2217-2227
DOI https://doi.org/10.1038/npp.2015.65
Keywords Pharmacology; Psychiatry and Mental health
Public URL https://nottingham-repository.worktribe.com/output/3051783
Publisher URL https://www.nature.com/articles/npp201565
Additional Information Received: 21 October 2014; Revised: 21 February 2015; Accepted: 25 February 2015; First Online: 9 March 2015